Koninklijke DSM Announces Dividend of $1.18 (OTCMKTS:RDSMY)

Koninklijke DSM (OTCMKTS:RDSMY) declared a dividend on Saturday, May 1st, investing.com reports. Shareholders of record on Tuesday, May 11th will be paid a dividend of 1.1771 per share by the basic materials company on Wednesday, May 19th. This represents a yield of 2.58%. The ex-dividend date of this dividend is Monday, May 10th.

Shares of RDSMY stock opened at $44.85 on Friday. The company has a market capitalization of $32.55 billion, a P/E ratio of 48.75, a P/E/G ratio of 4.94 and a beta of 0.84. The business’s 50 day moving average is $43.96 and its two-hundred day moving average is $43.03. The company has a current ratio of 2.69, a quick ratio of 1.86 and a debt-to-equity ratio of 0.47. Koninklijke DSM has a 12-month low of $29.31 and a 12-month high of $46.32.

Koninklijke DSM (OTCMKTS:RDSMY) last issued its quarterly earnings results on Tuesday, February 16th. The basic materials company reported $0.29 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.21 by $0.08. The company had revenue of $2.48 billion for the quarter. Koninklijke DSM had a return on equity of 9.81% and a net margin of 6.66%. On average, research analysts predict that Koninklijke DSM will post 1.27 earnings per share for the current fiscal year.

A number of brokerages have issued reports on RDSMY. Credit Suisse Group reiterated an “outperform” rating on shares of Koninklijke DSM in a research report on Wednesday, February 17th. UBS Group restated a “buy” rating on shares of Koninklijke DSM in a research report on Wednesday, February 17th. Sanford C. Bernstein downgraded Koninklijke DSM from a “market perform” rating to an “underperform” rating in a research report on Tuesday, January 12th. Zacks Investment Research downgraded Koninklijke DSM from a “hold” rating to a “sell” rating in a research report on Tuesday, April 27th. Finally, JPMorgan Chase & Co. assumed coverage on Koninklijke DSM in a research report on Monday, April 19th. They issued an “overweight” rating on the stock. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and six have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $49.00.

About Koninklijke DSM

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, rest of Europe, North America, Latin America, China, India, Japan, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments.

Featured Article: How to interpret Moving Average Convergence Divergence (MACD)

Receive News & Ratings for Koninklijke DSM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke DSM and related companies with MarketBeat.com's FREE daily email newsletter.